Work

[p1–056]: Population Pharmacokinetic‐pharmacodynamic (pk/pd) Modeling of E2027, a Selective Phosphodiesterase‐9 (pde9) Inhibitor, Following Single Ascending Oral Doses in Healthy Volunteers